MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

February 23, 2016

Thousands of men, women, and children are stranded between Greece and the Balkans after the sudden imposition of new border restrictions for Afghan refugees on the Western Balkans route this week. Refugees are being provided with no information and little-to-no humanitarian assistance, and are at risk of violence and abuse.

September 16, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) has reinforced its teams on the Serbian side of the border with Hungary following the closure of the Hungarian border, which is leading to a rapidly increasing number of refugees stranded on the Serbian side. Part of the MSF team that was working in Roszke (Hungary) for the last several weeks is currently supporting the teams in Horgos (Serbia) now that the Roszke camp is empty.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

February 23, 2016

Thousands of men, women, and children are stranded between Greece and the Balkans after the sudden imposition of new border restrictions for Afghan refugees on the Western Balkans route this week. Refugees are being provided with no information and little-to-no humanitarian assistance, and are at risk of violence and abuse.

September 16, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) has reinforced its teams on the Serbian side of the border with Hungary following the closure of the Hungarian border, which is leading to a rapidly increasing number of refugees stranded on the Serbian side. Part of the MSF team that was working in Roszke (Hungary) for the last several weeks is currently supporting the teams in Horgos (Serbia) now that the Roszke camp is empty.